Overexpression of TRPM7 is associated with poor prognosis in human ovarian carcinoma

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 9, 2014, Pages 3955-3958

  Wang, Jing ^a,b   Xiao, Ling ^c   Luo, Chen Hui ^b   Zhou, Hui ^b   Hu, Jun ^b   Tang, Yu Xi ^b   Fang, Kai Ning ^b   Zhang, Yi ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Ion channel; Ovarian cancer; Prognosis; TRPM7

Indexed keywords

MESSENGER RNA; PROTEIN SERINE THREONINE KINASE; TRANSIENT RECEPTOR POTENTIAL CHANNEL M; TRPM7 PROTEIN, HUMAN; TUMOR MARKER;

BIOSYNTHESIS; CANCER STAGING; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METASTASIS; MIDDLE AGED; MORTALITY; OVARY TUMOR; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; REAL TIME POLYMERASE CHAIN REACTION;

BIOMARKERS, TUMOR; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROPORTIONAL HAZARDS MODELS; PROTEIN-SERINE-THREONINE KINASES; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRPM CATION CHANNELS;

EID: 84902668623     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.9.3955     Document Type: Article

References (25)

1. Bian J, Li B, Kou XJ, et al (2013). Clinical significance of combined detection of serum tumor markers in diagnosis of patients with ovarian cancer. Asian Pac J Cancer Prev, 14, 6241-3.
2. Clapham, DE. (2003). TRP channels as cellular sensors. Nature, 426, 517-24.
3. Dhennin-Duthille I, Gautier M, Faouzi M, et al (2011). High expression of transient receptor potential channels in human breast cancer epithelial cells and tissues: correlation with pathological parameters. Cell Physiol Biochem, 28, 813-22.
4. Gao H, Chen X, Du X, et al (2011). EGF enhances the migration of cancer cells by up-regulation of TRPM7. Cell Calcium, 50, 559-68.
5. Hanano T, Hara Y, Shi J, et al (2004). Involvement of TRPM7 in cell growth as a spontaneously activated Ca2+ entry pathway in human retinoblastoma cells. J Pharmacol Sci, 95, 403-19.
6. He L, Peng K, Liu Y, et al (2013). Low expression of mixed lineage kinase domain-like protein is associated with poor prognosis in ovarian cancer patients. Onco Targets Ther, 6, 1539-43.
7. Jiang J, Li MH, Inoue K, et al (2007). Transient receptor potential melastatin 7-like current in human head and neck carcinoma cells: role in cell proliferation. Cancer Res, 67, 10929-38.
8. Kim K, Zang R, Choi SC, et al (2009). Current status of gynecological cancer in China. J Gynecol Oncol, 20, 72-6.
9. Ma SH, Kim BG, Choi JY, et al (2012). Korean epithelial ovarian cancer study (Ko-EVE): protocols and interim report. Asian Pac J Cancer Prev, 13, 3731-40.
10. Middelbeek J, Kuipers AJ, Henneman L, et al (2012). TRPM7 is required for breast tumor cell metastasis. Cancer Res, 72, 4250-61.
11. 2+ signaling. Cell Calcium, 40, 261-75.
12. Nadler MJ, Hermosura MC, Inabe K, et al (2001). LTRPC7 is a Mg.ATP-regulated divalent cation channel required for cell viability. Nature, 411, 590-5.
13. Paravicini TM, Chubanov V, and Gudermann T. (2012). TRPM7: a unique channel involved in magnesium homeostasis. Int J Biochem Cell Biol, 44, 1381-4.
14. Pham DL, Scheble V, Bareiss P, et al (2013). SOX2 expression and prognostic significance in ovarian carcinoma. Int J Gynecol Pathol, 32, 358-67.
15. Pitakkarnkul S, Tangjitgamol S, Srijaipracharoen, et al (2013). Treatment outcomes of paclitaxel for refractory or recurrent epithelial ovarian cancer patients in Thailand. Asian Pac J Cancer Prev, 14, 2421-7.
16. Prevarskaya N, Zhang L, and Barritt G. (2007). TRP channels in cancer. Biochim Biophys Acta, 1772, 937-46.
17. Qiu JJ, Guo JJ, Lv TJ, et al (2013). Prognostic value of centromere protein-A expression in patients with epithelial ovarian cancer. Tumour Biol, 34, 2971-5.
18. Ramsey IS, Delling M, and Clapham DE. (2006). An introduction to TRP channels. Annu Rev Physiol, 68, 619-47.
19. Rybarczyk P, Gautier M, Hague F, et al (2012). Transient receptor potential melastatin-related 7 channel is overexpressed in human pancreatic ductal adenocarcinomas and regulates human pancreatic cancer cell migration. Int J Cancer, 131, E851-61.
20. Siegel R, Naishadham D, and Jemal A. (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30.
21. Thigpen T, duBois A, McAlpine J, et al (2011). First-line therapy in ovarian cancer trials. Int J Gynecol Cancer, 21, 756-62.
22. Vaughan S, Coward JI, Bast RC, et al (2011). Rethinking ovarian cancer: recommendations for improving outcomes. Nat Rev Cancer, 11, 719-25.
23. Wang B, Liu SZ, Zheng RS, et al (2014). Time trends of ovarian cancer incidence in china. Asian Pac J Cancer Prev, 15, 191-3.
24. Yee NS, Chan AS, Yee JD, and Yee RK. (2012a). TRPM7 and TRPM8 ion channels in pancreatic adenocarcinoma: potential roles as cancer biomarkers and targets. Scientifica, 2012, 415158.
25. Yee NS, Zhou W, Lee M, and Yee RK. (2012b). Targeted silencing of TRPM7 ion channel induces replicative senescence and produces enhanced cytotoxicity with gemcitabine in pancreatic adenocarcinoma. Cancer Lett, 318, 99-105.